Cargando…
Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care
BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 commun...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210296/ https://www.ncbi.nlm.nih.gov/pubmed/37231438 http://dx.doi.org/10.1186/s12888-023-04883-w |
_version_ | 1785047039801819136 |
---|---|
author | Cui, Liang Zhang, Zhen Huang, Lin Li, Qinjie Guo, Yi-Han Guo, Qi-Hao |
author_facet | Cui, Liang Zhang, Zhen Huang, Lin Li, Qinjie Guo, Yi-Han Guo, Qi-Hao |
author_sort | Cui, Liang |
collection | PubMed |
description | BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 community-dwelling participants were recruited, including those with normal cognition (NC, n = 1,008), mild cognitive impairment (MCI, n = 633), and Alzheimer’s disease (AD, n = 131), and administered a neuropsychological test battery and the DuCA. To improve performance, the DuCA combines visual and auditory memory tests for an enhanced memory function test. RESULTS: The correlation coefficient between DuCA-part 1 and DuCA-total was 0.84 (P < 0.001). The correlation coefficients of DuCA-part 1 with Addenbrooke’s Cognitive Examination III (ACE-III) and Montreal Cognitive Assessment Basic (MoCA-B) were 0.66 (P < 0.001) and 0.85 (P < 0.001), respectively. The correlation coefficients of DuCA-total with ACE-III and MoCA-B were 0.78 (P < 0.001) and 0.83 (P < 0.001), respectively. DuCA-Part 1 showed a similar discrimination ability for MCI from NC (area under curve [AUC] = 0.87, 95%CI 0.848–0.883) as ACE III (AUC = 0.86, 95%CI 0.838–0.874) and MoCA-B (AUC = 0.85, 95%CI 0.830–0.868). DuCA-total had a higher AUC (0.93, 95%CI: 0.917–0.942). At different education levels, the AUC was 0.83–0.84 for DuCA-part 1, and 0.89–0.94 for DuCA-total. DuCA-part 1 and DuCA-total’s ability to discriminate AD from MCI was 0.84 and 0.93, respectively. CONCLUSION: DuCA-Part 1 would aid rapid screening and supplemented with the second part for a complete assessment. DuCA is suited for large-scale cognitive screening in primary care, saving time and eliminating the need for extensively training assessors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-04883-w. |
format | Online Article Text |
id | pubmed-10210296 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-102102962023-05-26 Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care Cui, Liang Zhang, Zhen Huang, Lin Li, Qinjie Guo, Yi-Han Guo, Qi-Hao BMC Psychiatry Research BACKGROUND: Aging population has led to an increased proportion of older adults and cognitively impaired. We designed a brief and flexible two-stage cognitive screening scale, the Dual-Stage Cognitive Assessment (DuCA), for cognitive screening in primary care settings. METHOD: In total, 1,772 community-dwelling participants were recruited, including those with normal cognition (NC, n = 1,008), mild cognitive impairment (MCI, n = 633), and Alzheimer’s disease (AD, n = 131), and administered a neuropsychological test battery and the DuCA. To improve performance, the DuCA combines visual and auditory memory tests for an enhanced memory function test. RESULTS: The correlation coefficient between DuCA-part 1 and DuCA-total was 0.84 (P < 0.001). The correlation coefficients of DuCA-part 1 with Addenbrooke’s Cognitive Examination III (ACE-III) and Montreal Cognitive Assessment Basic (MoCA-B) were 0.66 (P < 0.001) and 0.85 (P < 0.001), respectively. The correlation coefficients of DuCA-total with ACE-III and MoCA-B were 0.78 (P < 0.001) and 0.83 (P < 0.001), respectively. DuCA-Part 1 showed a similar discrimination ability for MCI from NC (area under curve [AUC] = 0.87, 95%CI 0.848–0.883) as ACE III (AUC = 0.86, 95%CI 0.838–0.874) and MoCA-B (AUC = 0.85, 95%CI 0.830–0.868). DuCA-total had a higher AUC (0.93, 95%CI: 0.917–0.942). At different education levels, the AUC was 0.83–0.84 for DuCA-part 1, and 0.89–0.94 for DuCA-total. DuCA-part 1 and DuCA-total’s ability to discriminate AD from MCI was 0.84 and 0.93, respectively. CONCLUSION: DuCA-Part 1 would aid rapid screening and supplemented with the second part for a complete assessment. DuCA is suited for large-scale cognitive screening in primary care, saving time and eliminating the need for extensively training assessors. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12888-023-04883-w. BioMed Central 2023-05-25 /pmc/articles/PMC10210296/ /pubmed/37231438 http://dx.doi.org/10.1186/s12888-023-04883-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Cui, Liang Zhang, Zhen Huang, Lin Li, Qinjie Guo, Yi-Han Guo, Qi-Hao Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title | Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title_full | Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title_fullStr | Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title_full_unstemmed | Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title_short | Dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
title_sort | dual-stage cognitive assessment: a two-stage screening for cognitive impairment in primary care |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10210296/ https://www.ncbi.nlm.nih.gov/pubmed/37231438 http://dx.doi.org/10.1186/s12888-023-04883-w |
work_keys_str_mv | AT cuiliang dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare AT zhangzhen dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare AT huanglin dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare AT liqinjie dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare AT guoyihan dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare AT guoqihao dualstagecognitiveassessmentatwostagescreeningforcognitiveimpairmentinprimarycare |